Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
Healthcare
Biotechnology
$6.55
$0.20(3.18%)

WuXi Biologics (Cayman) Inc. WXXWY Peers

See (WXXWY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXXWY$6.55+3.18%13.5B29.64$0.22N/A
NONOF$70.88+2.02%308.9B19.22$3.62+2.45%
CSLLY$79.16-0.05%151.8B28.82$2.72+1.69%
CMXHF$163.07+6.57%79B29.92$5.45+1.70%
UCBJY$98.14-0.62%37.3B31.17$3.15+0.80%
UCBJF$199.89-1.02%37.1B31.03$6.29+0.81%
ARGNF$547.18-2.64%33.4B33.32$16.42N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$10.24-0.89%16.9B-1024.50-$0.01N/A
WXIBF$3.18-2.15%12.9B28.91$0.11N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXXWY vs NONOF Comparison

WXXWY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXXWY stands at 13.5B. In comparison, NONOF has a market cap of 308.9B. Regarding current trading prices, WXXWY is priced at $6.55, while NONOF trades at $70.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXXWY currently has a P/E ratio of 29.64, whereas NONOF's P/E ratio is 19.22. In terms of profitability, WXXWY's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, WXXWY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXXWY.

Stock Price Comparison

Loading...

Frequently Asked Questions

;